68Ga-PSMA-11 PET/CT mapping of prostate cancer biochemical recurrence after radical prostatectomy in 270 patients with a PSA level of less than 1.0 ng/mL: impact …

…, I Rauscher, NS Schmidt-Hegemann… - Journal of Nuclear …, 2018 - Soc Nuclear Med
Target volume delineations for prostate cancer (PCa) salvage radiotherapy (SRT) after
radical prostatectomy are usually drawn in the absence of visibly recurrent disease. Ga-labeled …

[HTML][HTML] Recent advances of PET imaging in clinical radiation oncology

…, O Roengvoraphoj, NS Schmidt-Hegemann… - Radiation …, 2020 - Springer
Radiotherapy and radiation oncology play a key role in the clinical management of patients
suffering from oncological diseases. In clinical routine, anatomic imaging such as contrast-…

Outcome after PSMA PET/CT–based salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy: a 2-institution retrospective analysis

NS Schmidt-Hegemann, C Stief, TH Kim… - Journal of Nuclear …, 2019 - Soc Nuclear Med
Prostate-specific membrane antigen (PSMA) PET/CT detects prostate cancer recurrence at
low levels of prostate-specific antigen (PSA). Radiotherapy with dose escalation to the former …

[HTML][HTML] Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy

NS Schmidt-Hegemann, WP Fendler, H Ilhan… - Radiation …, 2018 - Springer
Background PSMA PET/CT visualises prostate cancer residual disease or recurrence at
lower PSA levels compared to conventional imaging and results in a change of treatment in a …

Development and validation of a multi-institutional nomogram of outcomes for PSMA-PET–based salvage radiotherapy for recurrent prostate cancer

…, L Emmett, A Arnoux, NS Schmidt-Hegemann - JAMA Network …, 2023 - jamanetwork.com
Importance Prostate-specific antigen membrane positron-emission tomography (PSMA-PET)
is increasingly used to guide salvage radiotherapy (sRT) after radical prostatectomy for …

Impact of 68Ga-PSMA PET/CT on the radiotherapeutic approach to prostate cancer in comparison to CT: a retrospective analysis

NS Schmidt-Hegemann, C Eze, M Li… - Journal of Nuclear …, 2019 - Soc Nuclear Med
68 Ga-prostate-specific membrane antigen PET/CT ( 68 Ga-PSMA PET/CT) offers
unprecedented accuracy for staging of primary, persistent, or recurrent prostate cancer. Thus, we …

[HTML][HTML] Radiotherapy of oligometastatic prostate cancer: a systematic review

P Rogowski, M Roach, NS Schmidt-Hegemann… - Radiation …, 2021 - Springer
Background Due to improved imaging sensitivity, the term “oligometastatic” prostate cancer
disease is diagnosed more often, leading to an increasing interest in metastasis-directed …

[HTML][HTML] PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC—current state and future directions

C Eze, NS Schmidt-Hegemann, LM Sawicki… - European journal of …, 2021 - Springer
Purpose The advent of immune checkpoint inhibitors (ICIs) has revolutionized the treatment
of advanced NSCLC, leading to a string of approvals in recent years. Herein, a narrative …

[HTML][HTML] Chemoradioimmunotherapy of inoperable stage III non-small cell lung cancer: immunological rationale and current clinical trials establishing a novel …

…, M Dantes, NS Schmidt-Hegemann… - Radiation …, 2020 - Springer
Immune-checkpoint inhibitors (ICI) have dramatically changed the landscape of lung cancer
treatment. Preclinical studies investigating combination of ICI with radiation show a …

Validation of different PSMA-PET/CT-based contouring techniques for intraprostatic tumor definition using histopathology as standard of reference

…, K Reichel, NS Schmidt-Hegemann… - Radiotherapy and …, 2019 - Elsevier
Purpose Accurate definition of the intraprostatic gross tumor volume (GTV) is crucial for
diagnostic and therapeutic approaches in patients with primary prostate cancer (PCa). The …